Cogent data has positive read-through to Blueprint, says Barclays
PremiumThe FlyCogent data has positive read-through to Blueprint, says Barclays
15d ago
Cogent Biosciences down after bezuclastinib abstract released
Premium
The Fly
Cogent Biosciences down after bezuclastinib abstract released
15d ago
Blueprint should rally on today’s Cogent data, says Oppenheimer
Premium
The Fly
Blueprint should rally on today’s Cogent data, says Oppenheimer
15d ago
Cogent Biosciences announces trials in patients with GIST completes enrollment
PremiumThe FlyCogent Biosciences announces trials in patients with GIST completes enrollment
3M ago
Cogent Biosciences price target lowered to $20 from $26 at Guggenheim
Premium
The Fly
Cogent Biosciences price target lowered to $20 from $26 at Guggenheim
4M ago
Cogent Biosciences expects cash to fund operations into 2027
Premium
The Fly
Cogent Biosciences expects cash to fund operations into 2027
4M ago
Cogent Biosciences names Cole Pinnow chief commercial officer
PremiumThe FlyCogent Biosciences names Cole Pinnow chief commercial officer
6M ago
3 Best Stocks to Buy Now, 5/8/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 5/8/2024, According to Top Analysts 
7M ago
Cogent Biosciences reports Q1 EPS (62c), consensus (52c)
Premium
The Fly
Cogent Biosciences reports Q1 EPS (62c), consensus (52c)
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100